JP2024509907A5 - - Google Patents
Info
- Publication number
- JP2024509907A5 JP2024509907A5 JP2023555193A JP2023555193A JP2024509907A5 JP 2024509907 A5 JP2024509907 A5 JP 2024509907A5 JP 2023555193 A JP2023555193 A JP 2023555193A JP 2023555193 A JP2023555193 A JP 2023555193A JP 2024509907 A5 JP2024509907 A5 JP 2024509907A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- liquid pharmaceutical
- composition according
- approximately
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159236P | 2021-03-10 | 2021-03-10 | |
| US63/159,236 | 2021-03-10 | ||
| US202263296032P | 2022-01-03 | 2022-01-03 | |
| US63/296,032 | 2022-01-03 | ||
| PCT/IL2022/050269 WO2022190100A1 (en) | 2021-03-10 | 2022-03-09 | Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024509907A JP2024509907A (ja) | 2024-03-05 |
| JP2024509907A5 true JP2024509907A5 (https=) | 2025-03-18 |
Family
ID=83226570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555193A Pending JP2024509907A (ja) | 2021-03-10 | 2022-03-09 | レボドパ－チロシンコンジュゲートを含む安定した液体組成物およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240207410A1 (https=) |
| EP (1) | EP4305049A4 (https=) |
| JP (1) | JP2024509907A (https=) |
| KR (1) | KR20230155508A (https=) |
| AU (1) | AU2022232759A1 (https=) |
| BR (1) | BR112023018202A2 (https=) |
| CA (1) | CA3211324A1 (https=) |
| IL (1) | IL305717A (https=) |
| MX (1) | MX2023010450A (https=) |
| TW (1) | TW202302621A (https=) |
| WO (1) | WO2022190100A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250082595A1 (en) * | 2022-01-03 | 2025-03-13 | Neuroderm, Ltd. | Methods and compositions for treating parkinson’s disease |
| CN116850159B (zh) * | 2023-07-12 | 2025-08-22 | 浙江同伍生物医药有限公司 | 一种盐酸左沙丁胺醇雾化吸入溶液组合物及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4035507A (en) * | 1975-04-17 | 1977-07-12 | Interx Research Corporation | Novel, transient pro-drug forms of L-DOPA to treat Parkinson's disease |
| ES2070994T3 (es) * | 1989-04-20 | 1995-06-16 | Zambon Spa | Profarmaco de dopamina. |
| US8207369B2 (en) * | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
| PT2640358T (pt) * | 2010-11-15 | 2018-02-23 | Neuroderm Ltd | Administração contínua de l-dopa, inibidores de dopa descarboxilase, inibidores de catecol-o-metil transferase e composições para os mesmos |
| RU2021103000A (ru) * | 2014-10-21 | 2021-03-01 | Эббви Инк. | Пролекарства карбидопа и l-dopa и их применение для лечения болезни паркинсона |
| WO2018154447A1 (en) * | 2017-02-21 | 2018-08-30 | Neuroderm Ltd | Dopa decarboxylase inhibitor compositions |
| CN110294789A (zh) * | 2018-03-21 | 2019-10-01 | 海南大学 | 含多巴寡肽的合成方法及其在抗帕金森病前药方面的应用 |
| AU2019359520A1 (en) * | 2018-10-08 | 2021-04-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
| WO2020178810A1 (en) * | 2019-03-04 | 2020-09-10 | Neuroderm, Ltd. | Pharmaceutical compositions comprising levodopa amide derivatives and uses thereof |
| PH12022550512A1 (en) * | 2019-09-05 | 2023-09-04 | Neuroderm Ltd | Liquid compositions comprising a levodopa amino acid conjugate and uses thereof |
-
2022
- 2022-03-09 BR BR112023018202A patent/BR112023018202A2/pt unknown
- 2022-03-09 WO PCT/IL2022/050269 patent/WO2022190100A1/en not_active Ceased
- 2022-03-09 EP EP22766532.0A patent/EP4305049A4/en active Pending
- 2022-03-09 MX MX2023010450A patent/MX2023010450A/es unknown
- 2022-03-09 KR KR1020237033788A patent/KR20230155508A/ko active Pending
- 2022-03-09 JP JP2023555193A patent/JP2024509907A/ja active Pending
- 2022-03-09 IL IL305717A patent/IL305717A/en unknown
- 2022-03-09 AU AU2022232759A patent/AU2022232759A1/en not_active Abandoned
- 2022-03-09 CA CA3211324A patent/CA3211324A1/en active Pending
- 2022-03-09 US US18/549,452 patent/US20240207410A1/en active Pending
- 2022-03-10 TW TW111108871A patent/TW202302621A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024509907A5 (https=) | ||
| JP6231145B2 (ja) | Ｌ−ドーパ、ドーパデカルボキシラーゼ阻害剤、カテコール−ｏ−メチルトランスフェラーゼ阻害剤、およびそれらのための組成物の継続的投与 | |
| US5719119A (en) | Parenteral nutrition therapy with amino acids | |
| CN100367949C (zh) | 黑色素消除制剂 | |
| BR9910508B1 (pt) | preparações farmacêuticas estabilizadas de derivados de ácido gama-aminobutìrico. | |
| CN106572986A (zh) | 用于经皮递送的方法和组合物 | |
| JPS61247354A (ja) | 栄養素組成物 | |
| KR20220103918A (ko) | 레보도파 아미노산 접합체를 포함하는 액체 조성물 및 그의 용도 | |
| US20240207410A1 (en) | Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereof | |
| JP2025504247A5 (https=) | ||
| RU2023125739A (ru) | Стабилизированные жидкие композиции, содержащие конъюгат леводопа-тирозин, и их применения | |
| EP1202956B1 (en) | Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same | |
| JP2011195516A (ja) | 制がん剤 | |
| US20230157985A1 (en) | Methods for treatment of parkinson's disease | |
| JP2025502857A (ja) | パーキンソン病を処置するための方法および組成物 | |
| WO2007064784A1 (en) | Inhibitors of kynurenine aminotransferase and uses therefor | |
| RU2024121996A (ru) | Способы и композиции для лечения болезни паркинсона | |
| JP2021155334A (ja) | 中分子ヘパリンまたは中分子ヘパリンのアミノ酸誘導体を含む医薬組成物 | |
| CN116964069A (zh) | 包含左旋多巴-酪氨酸缀合物的稳定化的液体组合物及其用途 |